A GCC ministry-of-health tender is not won on price alone; it is won on whether your package is complete the day it lands. Across Saudi Arabia, the UAE, Qatar, Kuwait, Oman and Bahrain the document set is broadly the same seven items, but each state sets its own validity, format and local-representative rules, and each tender can add its own. Here is the working list M Care Exports uses, document by document, with where Indian bids actually stall.
1. The CTD dossier itself, Modules 1 through 5.
The Common Technical Document is the backbone. Module 1 is country-specific (each GCC state has its own administrative overlay), while Modules 2 through 5 are broadly harmonised under ICH guidance. Submission formats differ by state: UAE EDE publishes an eCTD structure for Module 1, and Bahrain NHRA's medicine licensing guideline (v4.1, October 2025) asks for the dossier in eCTD format, uploaded by the applicant. Check each regulator's current submission format before you build the package.
The Module 1 overlay matters most. Saudi SFDA requires the patient leaflet in Arabic and English, with the SPC in English, and each of the other states sets its own Module 1 list, so take it from the regulator's current guidance and the tender documents. The dossier preparation team at our Mumbai desk runs through the CTD dossier preparation workflow per country; one master CTD with six Module 1 overlays is how we keep the package consistent.
Where bids stall: Module 1 overlay missed on one state. We have seen submissions with strong M2 to M5 sit for weeks because the Saudi PC pricing annex was not attached. Lead country reviewers do not raise the issue until the substantive review begins, so the clarification clock is wasted.
2. CoPP, the WHO Type Certificate of Pharmaceutical Product.
The CoPP is the WHO-format certificate that the exporting country's competent authority issues for a named product. In India, CoPPs for Indian-made medicines are issued by the state drug regulator (the State Licensing Authority) on the basis of a joint CDSCO and state inspection of the manufacturer, and the manufacturer files the application on the ONDLS portal. None of the official texts we could read says the CoPP must name the importing country; Bahrain NHRA does require the product name on the CPP to be the name proposed for Bahrain. On the ONDLS portal the manufacturer selects a country when applying for a CoPP, so check the wording the tender documents expect before you apply.
Validity: we found no official text that sets an age limit in months for the CoPP. SFDA's Data Requirements for Human Drugs Submission (V4.0, latest revision 3 August 2025) say a CPP is optional and no longer required for new marketing authorisation applications in any pathway, although SFDA may ask for one at any time and, if one is needed, it should follow the WHO format. SFDA's Registration Rules (2022) still require a CPP or free sale certificate from a stringent regulatory authority where an imported product is not registered and marketed in its country of origin. UAE EDE asks for an original, legalised, valid CPP and, at renewal, a recent copy attested by the UAE Embassy. Bahrain NHRA asks for a CPP in WHO format, legalised, and valid for at least three months at the time of submission. Oman MoH says all certificates must be approved and valid, and for products not registered in Qatar, HMC's quotation terms say all supporting documents must be valid, harmonised and matching the offered products. We could not read the official Kuwait text or the Qatar Ministry of Public Health registration pages, and we have not seen the GCC central registration guidelines or the NUPCO and Oman tender booklets, so an age limit may exist there. A tendering authority can set a stricter rule of its own, so take the validity requirement from the tender documents, which take priority over this guide. The WHO-GMP compliance service line manages this renewal cycle plus the underlying Site Master File and inspection-report bundle that supports CoPP issuance.
Where bids stall: a CoPP that does not match what the tender documents ask for (for example the product name or the importing-country wording), or one that has expired or is close to expiry on the bid date. Depending on the tender, these can be treated as missing documents rather than clarification items.
3. Authorised Local Representative (ALR) appointment letter.
In the three states where we could read the regulator's own text (Saudi Arabia, the UAE and Bahrain), a foreign manufacturer without a local licence must work through a local agent, applicant or distributor, and the rule, the entity type and the letter format differ by state. We could not read the equivalent Qatar Ministry of Public Health, Kuwait or Oman rules. The official texts we could read say the following. SFDA's Registration Rules say a foreign company without a Saudi commercial investment licence must appoint an agent for each product marketed in the Kingdom. UAE EDE's eCTD Module 1 lists an appointment letter for the local applicant or distributor, and its site-registration service asks for a legalised letter, attested by the UAE Embassy, authorising a local person or establishment to file. Bahrain NHRA requires medicine importation and distribution through an authorised pharmacy (the local agent), with the agency agreement notified to NHRA and acknowledged by it. Qatar HMC asks for an agency, sole agency or distributor authorisation letter issued by the manufacturer directly, not by its regional office, and recommends legalisation by the Qatar Embassy or notarisation. In Oman, Drug Safety Center circular 45/2026 requires private pharmacies and drug stores to buy only from authorised and licensed local agents, and circulars 51/2026 (18 May 2026) and 84/2026 (25 August 2026) suspended the acceptance of new medicine registration applications where Omani ownership of the local agent, or of the beneficiary of the registration, marketing or distribution, is below 100%, except for products of national manufacturers. The suspension runs in renewable three-month periods, so check whether it is still in force. We could not reach an official Kuwait text. We found no official text that sets an age limit for any of these letters.
A common misconception in new-applicant GCC tender bids is that one letter will do for every state. Each regulator we could read, and each tender, names its own applicant, agent or distributor and the letter it accepts, so plan one letter per destination and check each against that state's rules and the tender documents. Our MoH registration, GCC service line carries an ALR-network panel of vetted pharmaceutical distributors across the six states.
Where bids stall: an ALR letter naming an entity whose licence has lapsed between drafting and tender submission. Two-to-six-week clarification holds are common. Check that the representative's licence is current on the bid submission day, not the dossier preparation day.
4. GMP certificate and manufacturing licence.
The baseline is a valid GMP certificate for each manufacturing site, but the regulators word it differently. SFDA asks for a valid GMP certificate, and one for each site where the major production steps are carried out. UAE EDE asks for valid GMP certificates for the manufacturing sites. Bahrain NHRA asks for valid GMP certificates for the finished-product manufacturer, bulk manufacturer, packagers and batch releaser, and for the active ingredient sites. Qatar HMC's form for products not registered in Qatar asks for valid WHO-standard GMP, GDP or WDA certificates, or equivalent, for all manufacturing and packaging sites. For an Indian manufacturer, the WHO-GMP certificate is issued through the state drug regulator (the State Licensing Authority) on the basis of a joint CDSCO and state inspection, and its validity is the period printed on the certificate. The manufacturing licence (Form 25 or 28, depending on category) issued by the relevant Indian state Drugs Control Department must be current and name the dosage form on the licence.
Validity: we found no official text that sets a maximum age in months for a GMP certificate. SFDA and UAE EDE ask for a valid certificate, Bahrain NHRA asks for one valid for at least three months at the time of submission, and, for products not registered in Qatar, HMC's quotation terms require all supporting documents to be valid, harmonised and matching the offered products. Check the expiry date printed on each certificate against the tender closing date, and take any stricter rule from the tender documents. The WHO-GMP compliance service tracks renewal scheduling and inspection-readiness ahead of tender opening windows.
Where bids stall: an expired GMP certificate where the original inspection was clean but the renewal was delayed by inspection scheduling. We have seen otherwise-strong bids fall to clarification because the GMP certificate had expired by the day the tender closed.
5. Site Master File.
The Site Master File describes the manufacturing site, and the PIC/S explanatory notes (PE 008-4) organise it into general information, the quality management system, personnel, premises and equipment, documentation, production, quality control, distribution, complaints, product defects and recalls, and self-inspection. SFDA's Site Master File guidance follows the PIC/S explanatory notes. UAE EDE asks for a Site Master File for manufacturer site registration and marks it as not mandatory in its user guide, and Bahrain NHRA accepts an SMF as one form of company profile; neither states a format. For other destinations, take the format from the tender documents.
Validity: we found no official text that sets an age limit in months for the Site Master File. SFDA's guidance asks for an edition number, an effective date and a review date, says the file should be reviewed regularly so that it stays up to date and representative of current activities, and asks for a copy of the current GMP certificate. UAE EDE and Bahrain NHRA state no age limit. Keep the SMF current, and take any age rule from the tender documents. The CTD dossier preparation service line keeps the SMF on the same review calendar as the Module 3 quality dossier.
Where bids stall: an SMF that does not follow the format the destination expects; in our GCC tender history this is the most common reason for clarification holds. SFDA's guidance follows the PIC/S explanatory notes, so use that format for Saudi Arabia and check the tender documents elsewhere.
6. Batch CoA and Climatic Zone IVa stability data.
Three consecutive production batches' Certificates of Analysis (CoA) plus a stability data package are mandatory. The GCC stability guideline places the Gulf states in climatic zones III and IVa, so the long-term condition is 30 degrees Celsius / 65 percent relative humidity. Most Indian manufacturers default to Zone II stability (25 degrees Celsius / 60 percent relative humidity), which alone is insufficient for Gulf regulators. WHO guidance treats a harsher long-term condition as an acceptable alternative, so a Zone IVb package at 30 degrees Celsius / 75 percent RH can also serve.
The acceptable stability package: at least twelve months of Zone IVa long-term data at submission, plus accelerated stability at 40 degrees Celsius / 75 percent RH for six months. For thermolabile injectables and biologicals, 2 to 8 degrees Celsius long-term data plus excursion-tolerance studies replace the Zone IVa requirement. Cold-chain dossier overlays (qualified shipper specs, temperature excursion data, conformance to USP 1079 and PDA TR 39) sit in Module 3.2.P. The cold-chain validation service line manages the excursion-tolerance documentation for sensitive products bound for Doha Hamad International, Riyadh King Khaled International, Dubai International and Kuwait International airports.
Where bids stall: Zone II stability data submitted for a Gulf destination, where the manufacturer believed the WHO-GMP CoPP would be sufficient. It is not.
7. Pricing reference list with International Reference Pricing (IRP).
Each GCC state has a Pricing Committee that sets ceiling ex-factory prices using International Reference Pricing benchmarks. Saudi SFDA's Pricing Committee references prices in Saudi Arabia, UAE, Jordan, Egypt, Lebanon, France, Spain, Italy, Turkey and the originator's home country. UAE EDE, Qatar MoPH, Kuwait MOH-DFC and Bahrain NHRA each use overlapping but not identical reference baskets. GCC Central Registration adds a unified-pricing layer on top: the lead country's Pricing Committee sets the ceiling and that ceiling must hold across the six states.
For NUPCO tenders in Saudi Arabia, the published unified-pricing ceiling is the upper bound; tender bids come in twenty to thirty percent below the ceiling for established generic molecules. Submitting different ex-factory prices to different GCC states triggers a Pricing Committee investigation. The pricing reference list submitted with the tender must show: (a) the ex-factory price proposed, (b) the unified-pricing ceiling, (c) the IRP basket reference prices used to derive the ceiling, (d) any locked-in prices from prior GCC tender awards. Our GCC tender response service line prepares this comparison table per molecule per tender opening.
Where bids stall: the IRP basket reference prices not current. Reference prices update through the year; an out-of-date reference price submitted with the tender is treated as a pricing-misrepresentation flag and triggers a separate Pricing Committee review track outside the technical evaluation. Verify reference prices the week of tender close, not the week of dossier preparation.
Pre-bid checklist, the night before tender close.
1. CTD M1 overlay
Module 1 for each destination built to that regulator's current guidance and the tender documents. For SFDA, the patient leaflet in Arabic and English and the SPC in English.
2. CoPP validity and wording
Valid on the day you submit and on the tender closing date (Bahrain NHRA: at least three months of validity at submission), in WHO format, and legalised where the regulator or tender asks for it (UAE EDE and Bahrain NHRA state this; confirm for the other states). Product name matches the tender documents (Bahrain NHRA: as proposed to Bahrain).
3. ALR letter currency
Local representative's licence confirmed current the day of tender submission, not the day of dossier preparation. Appointment letter in the form the regulator and the tender ask for.
4. GMP certificate validity
GMP certificate for every manufacturing site valid on the day you submit and on the tender closing date (Bahrain NHRA: at least three months of validity at submission). Form 25 or 28 manufacturing licence current.
5. SMF format and review
Site Master File in PIC/S format for SFDA, with edition number, effective date and review date. Any age limit taken from the tender documents.
6. Zone IVa stability
Long-term Zone IVa data, at least twelve months at submission, plus accelerated 40/75 six-month data. Excursion-tolerance for cold-chain SKUs.
7. IRP basket
Reference prices verified current the week of tender close. Unified-pricing ceiling calculated. Tender bid price compared against unified ceiling and prior award prices.
FAQ
Can one ALR letter cover all six GCC states?
Not safely. In the states whose rules we could read, a foreign manufacturer needs a licensed local agent, applicant or distributor, and the texts for Saudi Arabia, the UAE, Qatar (HMC) and Bahrain each set their own appointment requirements. For a foreign company without a Saudi commercial investment licence, Saudi Arabia asks for an agent for each product, the UAE for an appointment letter for the local applicant or distributor, Bahrain for an authorised pharmacy as local agent with the agreement acknowledged by NHRA, and Qatar HMC for an authorisation letter issued by the manufacturer directly. Plan one letter per destination and take the exact form from each regulator and each tender document. We could not read the Kuwait, Qatar Ministry of Public Health or Oman agent rules.
How old can the CoPP be when submitted?
The official texts we could read give no age limit in months for the CoPP. SFDA's data requirements (latest revision 3 August 2025) say a CPP is optional and no longer required for new marketing authorisation applications, although SFDA may ask for one, and its 2022 Registration Rules still require one from a stringent regulatory authority where the product is not registered in its country of origin. UAE EDE asks for an original, legalised, valid CPP. Bahrain NHRA asks for a CPP in WHO format, legalised, valid for at least three months at the time of submission, with the product name as proposed to Bahrain. Oman MoH says all certificates must be approved and valid, and for products not registered in Qatar, HMC's quotation terms say all supporting documents must be valid, harmonised and matching the offered products. We could not read the official Kuwait text or the Qatar Ministry of Public Health registration pages, and we have not seen the GCC central registration guidelines or the NUPCO and Oman tender booklets, so an age limit may exist there. In India, CoPPs for Indian-made medicines are issued by the state drug regulator on the basis of a joint CDSCO and state inspection of the manufacturer. A tender can set its own validity rule, so take it from the tender documents and check the certificate's own validity against the closing date.
What climate zone stability is required for the GCC?
The GCC stability guideline places the Gulf states in climatic zones III and IVa. Long-term data runs at 30 degrees Celsius / 65 percent relative humidity, with at least 12 months at submission, plus accelerated data at 40 degrees Celsius / 75 percent RH for six months. Most Indian Zone II stability data (25 degrees Celsius / 60 percent RH) is insufficient on its own. Always confirm with the lead country before lodging.
Does GCC Central Registration replace single-country MoH filings?
Partially. GCC-DR replaces six parallel scientific reviews with one lead-country review (typically Saudi SFDA, UAE EDE or Bahrain NHRA). The lead country's positive opinion is then mutually recognised across the other five. However, each state still issues its own Marketing Authorisation, sets its own price under its own Pricing Committee, and prints its own Arabic-bilingual artwork. GCC-DR does not remove per-country administration.
What is the GCC unified pricing rule and how does it interact with NUPCO bids?
GCC unified pricing requires the same ex-factory price across the six member states, indexed to a basket of five reference countries (commonly Saudi Arabia, UAE, Egypt, Jordan and a benchmark European market). The Pricing Committee in the lead country sets the ceiling. For NUPCO tender bids in Saudi Arabia, the unified ceiling is the upper bound; bids can come in below the ceiling but never above. Bid awards in NUPCO are typically twenty to thirty percent below the unified ceiling for established generics.
Which document do bids most often stall on?
From our experience submitting through Indian generic manufacturer partners across the six GCC states: the Site Master File. SMFs not in the PIC/S format that SFDA follows, or out of date, are the single most common reason for clarification holds. Site Master File issues add two to four weeks of clock-stop per occurrence. Second most common: an expired GMP certificate. Third: ALR letter naming an entity that is no longer licensed in the destination.
Official sources
The regulators and official documents to check this guide against. Requirements change, so confirm the current version with the regulator before you file.
- ICH: M4 Organisation of the Common Technical Document for the Registration of Pharmaceuticals for Human Use (PDF)
- WHO: WHO certification scheme on the quality of pharmaceutical products
- PIC/S: Explanatory Notes for Pharmaceutical Manufacturers on the Preparation of a Site Master File, PE 008-4 (PDF)
- SFDA: The Registration Rules of Pharmaceutical, Herbal and Health Product Manufacturers and their Products (PDF)
- SFDA: GCC guideline for stability testing, version 3.4 (PDF)
- SFDA: Templates for Labelling Information, SPC and PIL, version 1.3 (PDF)
Send the molecule and the destination. We will scope the seven-document gap inside one working day.
Saudi NUPCO closing tomorrow. Kuwait CMSPS new RFT next week. Qatar HMC haematology tender in flight. Send molecule, strength, dosage form, target volume and destination state. Our Mumbai desk runs the seven-document gap analysis against the destination's current MoH requirements and tells you where the package needs work before the bid closes. See the full GCC tender response service for how the lane runs.
